Dr. Reddy's Laboratories Limited RDY (“Dr. Reddy's”), together
with its subsidiaries, announces the intended public offer to acquire
the issued and outstanding shares of OctoPlus N.V. (Euronext
Amsterdam:OCTO) (“OctoPlus”), a service-based specialty pharmaceutical
company, for an offer price of €27.39 million (cum dividend) in cash,
representing 100% of the issued and outstanding ordinary shares. The
offer price represents a premium of 30% over the closing price of
OctoPlus as of the EoD, October 19, 2012.
Dr. Reddy's currently holds an irrevocable commitment from shareholders
representing over 50% of OctoPlus's issued and outstanding shares.
Further, the Executive Board and the Supervisory Board of OctoPlus have
unanimously recommended the Offer to the remaining shareholders.
See full press release
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in